Insight 2811 Inc. Sells 200 Shares of Oracle Co. (NYSE:ORCL)

Insight 2811 Inc. lessened its stake in Oracle Co. (NYSE:ORCL) by 3.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,753 shares of the enterprise software provider’s stock after selling 200 shares during the period. Oracle accounts for approximately 0.4% of Insight 2811 Inc.’s investment portfolio, making the stock its 27th largest holding. Insight 2811 Inc.’s holdings in Oracle were worth $812,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ORCL. Westend Capital Management LLC purchased a new position in shares of Oracle in the 1st quarter worth approximately $25,000. Tidemark LLC purchased a new position in Oracle in the fourth quarter worth $29,000. Nordwand Advisors LLC acquired a new position in shares of Oracle during the fourth quarter worth $30,000. Frank Rimerman Advisors LLC purchased a new stake in shares of Oracle during the 4th quarter valued at $30,000. Finally, POM Investment Strategies LLC acquired a new stake in shares of Oracle in the 2nd quarter worth $30,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on ORCL shares. Evercore ISI upped their target price on Oracle from $145.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday, June 12th. DA Davidson reaffirmed a “neutral” rating and issued a $105.00 price objective on shares of Oracle in a research report on Wednesday, June 12th. Bank of America lifted their target price on shares of Oracle from $144.00 to $155.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 12th. Morgan Stanley restated an “equal weight” rating and set a $125.00 price target on shares of Oracle in a research note on Tuesday, June 25th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Oracle from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Monday, June 17th. Fourteen analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $145.87.

Insider Buying and Selling at Oracle

In related news, insider Edward Screven sold 235,918 shares of the company’s stock in a transaction dated Thursday, June 20th. The shares were sold at an average price of $144.30, for a total transaction of $34,042,967.40. Following the completion of the transaction, the insider now owns 2,626,764 shares in the company, valued at approximately $379,042,045.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Edward Screven sold 235,918 shares of Oracle stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total value of $34,042,967.40. Following the sale, the insider now directly owns 2,626,764 shares of the company’s stock, valued at $379,042,045.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey Berg sold 22,500 shares of the stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $143.12, for a total value of $3,220,200.00. Following the completion of the transaction, the director now directly owns 210,712 shares of the company’s stock, valued at $30,157,101.44. The disclosure for this sale can be found here. Insiders have sold a total of 1,862,500 shares of company stock valued at $266,776,624 over the last ninety days. Corporate insiders own 42.80% of the company’s stock.

Oracle Price Performance

Shares of ORCL stock traded down $0.80 during mid-day trading on Friday, hitting $141.81. 11,154,796 shares of the stock were exchanged, compared to its average volume of 8,056,655. Oracle Co. has a 52-week low of $99.26 and a 52-week high of $146.59. The company has a quick ratio of 0.72, a current ratio of 0.71 and a debt-to-equity ratio of 8.25. The company has a market cap of $390.81 billion, a PE ratio of 38.22, a price-to-earnings-growth ratio of 2.55 and a beta of 1.01. The firm has a fifty day moving average of $138.72 and a 200 day moving average of $128.47.

Oracle (NYSE:ORCL) last issued its quarterly earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). The business had revenue of $14.29 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Oracle had a return on equity of 223.01% and a net margin of 19.76%. The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.35 EPS. Research analysts anticipate that Oracle Co. will post 5.02 earnings per share for the current year.

Oracle Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 25th. Shareholders of record on Thursday, July 11th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Thursday, July 11th. Oracle’s dividend payout ratio is presently 43.13%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.